Joseph Klein III has sold IONS and made no open-market buys since Nov 2017

Joseph "Skip" Klein III is an independent director at Ionis Pharmaceuticals Inc (IONS) since December 2005, currently serving as Audit Committee Chair and Finance Committee member, where he is designated as the Audit Committee's financial expert due to his Chartered Financial Analyst (CFA) credential and extensive experience(

Klein, aged 63 as of March 1, 2025, is the Managing Director of Gauss Capital Advisors, a biopharma-focused advisory firm he founded in 1998( His career highlights include serving as founding portfolio manager of the T. Rowe Price Health Sciences Fund (1989–1998), VP of Strategy at Medical Manager Corporation (pre-merger with WebMD, 1999–2000), and venture partner roles at MPM Capital (2001–2002) and Red Abbey Venture Partners (2003–2008)( He has held prior directorships at public companies including Akcea Therapeutics (until its 2020 merger with Ionis), BioMarin, NPS, OSI, PDL BioPharma, and Savient, and currently serves on the board of The Prospector Funds( Recently, as a corporate insider, Klein executed Rule 10b5-1 trades, selling shares on September 3, 2025 ($1.68M) and November 25, 2025 ($960K) after exercising stock options, retaining direct ownership of 16,346 shares(

Written by Perplexity from public sources.